MGEN News and Press, Miragen Therapeutics Inc. From 06/18/20

Francesca's Holdings (NASDAQ: FRAN )  -24%  on Q1 results . More news on: Francesca's Holdings Corporation, Medley Management Inc., Brickell Biotech, Inc., Stocks on the move, , Read more ...

MiRagen Therapeutics (NASDAQ: MGEN ) will host a key opinion leader (KOL) call regarding ideopathic pulmonary fibrosis (IPF) on Tuesday, June 23, at 11:00 am ET. More news on: Miragen Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...

BOULDER, Colo., June 16, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced it is scheduled to host a key opinion leaders (KOL) call regarding idio...

The following slide deck was published by Miragen Therapeutics in conjunction with this Read more ...

 Gainers:  Sonoma Pharmaceuticals (NASDAQ: SNOA ) +145% . More news on: Sonoma Pharmaceuticals, Inc., Adaptimmune Therapeutics plc, Phio Pharmaceuticals Corp., Stocks on the move, , Read more ...

ARCA biopharma (NASDAQ: ABIO )  -28% . More news on: ARCA biopharma, Inc., ToughBuilt Industries, Inc., Canopy Growth Corporation, Stocks on the move, , Read more ...

Are These On Your List Of Penny Stocks To Watch Before June 2020? The stock market today is jumping again and so are a number of penny stocks . One thing brought to my attention was the misconception that penny stocks are meant for short-term day trades. Now, before I get to my point, let me ...

BOULDER, Colo., May 26, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S. Marshall, Ph.D., President and Chief Executive Officer o...

Miragen Therapeutics, Inc. (MGEN) Q1 2020 Earnings Conference Call May 7, 2020 16:30 ET Company Participants Dan Ferry - Managing Director of LifeSci Advisors Bill Marshall - President & Chief Executive Officer Jason Leverone - Chief Financial Officer Conference Call Parti...

Miragen Therapeutics (NASDAQ: MGEN ): Q1 GAAP EPS of -$0.18 beats by $0.03 . Revenue of $0.83M (+124.3% Y/Y) beats by $0.24M . Press Release More news on: Miragen Therapeutics, Earnings news and commentary, Healthcare stocks news, ,